{"schema_version":"secwatch.filing_event.v1","accession":"0001772016-22-000048","form_type":"8-K","ticker":"BRBR","cik":"0001772016","company_name":"BELLRING BRANDS, INC.","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.980163+00:00","generated_at":"2026-06-24T04:22:45.600548+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BellRing Q3 net sales $370.6M (+8.2%), adj. EBITDA $80.8M; updates FY2022 guidance","bullets":["Q3 net sales $370.6M (+8.2% YoY); Premier Protein +7.3% (volumes -9.4%), Dymatize +16.8% (volumes -28.0%).","GAAP diluted EPS $0.29; adjusted diluted EPS $0.31.","Adjusted EBITDA $80.8M (+14.6% YoY); nine-month adj. EBITDA $191.5M (+10.4%).","FY2022 guidance: net sales $1.39-$1.42B, adj. EBITDA $262-$268M (growth 11-14% and 12-15% vs FY2021).","Repurchased 0.1M shares for $2.4M in Q3; $47.6M remaining under authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0001772016-22-000048","json":"https://secwatch.observer/filing/0001772016-22-000048.json","markdown":"https://secwatch.observer/filing/0001772016-22-000048.md","text":"https://secwatch.observer/filing/0001772016-22-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1772016/000177201622000048/0001772016-22-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1772016/000177201622000048/brbrformxq32022earningsrel.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T04:22:45.600548+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}